Leishmanicidal Activity of an <i>In Silico</i> -Screened Novel Inhibitor against Ascorbate Peroxidase of Leishmania donovani
Mohammad Kashif, Ankush Paladhi, Ranjeet Singh, Sankar Bhattacharyya, Sumit Kumar Hira, Partha Pratim Manna
Abstract
-dibenzylquinazoline-2,4-diamine (DBeQ), targeting the D2-ATPase domain of the enzyme. ZINC96021026 (ML-240) thus has a broad range of cellular functions, thought to be derived from its ability to unfold proteins or disassemble protein complexes, besides inhibiting the ascorbate peroxidase activity. ML-240 may inhibit the parasite's ascorbate peroxidase, leading to extensive apoptosis and inducing generation of reactive oxygen species. Taken together, our results demonstrated that ML-240 could be an attractive therapeutic option for treatment against leishmaniasis.
Topics & Concepts
PeroxidaseAmastigoteBiochemistryLeishmaniaIn silicoLeishmania donovaniEnzymeBiologyIntracellularPharmacologyChemistryLeishmaniasisParasite hostingImmunologyVisceral leishmaniasisWorld Wide WebGeneComputer scienceResearch on Leishmaniasis Studies